Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Two MIT Professors Win Prestigious Wolf Prize

Published: Wednesday, January 09, 2013
Last Updated: Wednesday, January 09, 2013
Bookmark and Share
Michael Artin and Robert Langer honored for groundbreaking work in mathematics and chemistry.

MIT professors Michael Artin and Robert Langer are among eight recipients worldwide of the 2013 Wolf Prize, the Israel-based Wolf Foundation announced this week.

The prestigious international prizes are awarded annually in five categories, each worth $100,000; Artin and Langer were cited for their contributions in mathematics and chemistry, respectively. More than 30 Wolf Prize recipients have gone on to win the Nobel Prize.

Israeli President Shimon Peres will present the prizes in May at a special session hosted by the Knesset, the Israeli parliament.

Artin, a professor emeritus of mathematics at MIT, helped introduce and define a number of tools and theories in modern algebraic geometry, including the Artin Stack, which is a generalized version of an algebraic stack. His contributions to the theory of surface singularities introduced several concepts — such as rational singularity and fundamental cycle — that became seminal to the field.

“Artin is one of the main architects of modern algebraic geometry,” the Wolf Foundation said in announcing him as a winner of the Wolf Prize. “His fundamental contributions encompass a bewildering number of areas in this field. … He is one of the great geometers of the 20th century.”

In 2002, Artin won the American Mathematical Society’s annual Steele Prize for Lifetime Achievement; in 2005, he was awarded the Harvard Centennial Medal. Artin is also a member of the National Academy of Sciences, as well as a fellow of the American Academy of Arts and Sciences, the American Association for the Advancement of Science, the Society for Industrial and Applied Mathematics, and the American Mathematical Society.

Langer, the David H. Koch Institute Professor at MIT, focuses on developing new ways to administer drugs to patients. A biomedical engineer, he developed a variety of novel drug-delivery systems based on polymers, including materials that can release drugs continuously over a prolonged period of time. In the 1970s, Langer developed polymers that allowed the large molecules of a protein to pass through membranes in a controlled manner to inhibit angiogenesis, the process by which tumors recruit blood vessels.

“Robert Langer is primarily responsible for innovations in polymer chemistry that have had profound impact on medicine, particularly in the areas of drug delivery and tissue engineering,” the Wolf Foundation said in its announcement.

Last month, Langer was among 23 eminent researchers nationwide to be awarded the United States’ highest honors for scientists, engineers and inventors. He will receive the National Medal of Technology and Innovation from President Barack Obama at a ceremony this year.

Langer is a member of the Institute of Medicine, the National Academy of Engineering, and the National Academy of Sciences, making him one of only a few people to hold membership in three national academies. Over the years, he has earned more than 200 major awards in science, including the 2006 National Medal of Science, presented by the president of the United States to scientists and engineers who have made important contributions in their fields.

Wolf Prizes have been awarded since 1978 to outstanding scientists and artists “for achievements in the interest of mankind and friendly relations among peoples, irrespective of nationality, race, color, religion, sex or political view.” The prizes are presented annually in agriculture, chemistry, mathematics, medicine, and/or physics, as well as in the arts.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
Friday, January 29, 2016
Firms “Under-invest” in Long-Term Cancer Research
Tweaks to the R&D pipeline could create new drugs and greater social benefit.
Thursday, July 30, 2015
Chemists Recruit Anthrax to Deliver Cancer Drugs
With some tinkering, a deadly protein becomes an efficient carrier for antibody drugs.
Tuesday, September 30, 2014
New Approach to Global Health Challenges
MIT’s Institute for Medical Engineering and Science brings many tools to the quest for new disease treatments and diagnostic devices.
Friday, September 27, 2013
Chemists Find Help from Nature in Fighting Cancer
Study of several dozen compounds based on a fungal chemical shows potent anti-tumor activity.
Thursday, February 28, 2013
MIT Chemist Discovers Secret Behind Nature's Medicines
Chemists have the capability of a particular enzyme to reproduce antibiotics, anti-tumor agents, and fungicides.
Friday, April 28, 2006
Scientific News
Survey of New York City Soil Uncovers Medicine-Making Microbes
Microbes have long been an invaluable source of new drugs. And to find more, we may have to look no further than the ground beneath our feet.
Drug Design Strategy to Improve Breast Cancer Treatment
Scientists develop novel structure-based drug design strategy aimed at altering the basic landscape of hormone-driven breast cancer treatment.
`Molecular Commando’ Identified to Tackle Hypoxia Pathway
Scientists identify 'molecular commando' that can activate hypoxic response, which helps combat a number of conditions.
Peer Review is in Crisis, But Should be Fixed, Not Abolished
After the time to get the science done, peer review has become the slowest step in the process of sharing studies, and some scientists have had enough.
Two Antibiotics Fight Bacteria Differently Than Thought
Researchers discover that two widely prescribed antibiotics may fight bacteria differently than previously thought.
Drug Target for Gastrointestinal Stromal Tumors Identified
Researchers show the Hedgehog signaling pathway is central to the formation of gastrointestinal stromal tumors.
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Targeting Cannabinoid CB2 Receptors in the CNS
With endogenous cannabinoids considered as a potential target to combat CNS diseases, this article examines the role of CB2R could play in fighting some disorders.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!